T. Podskarbi et al., MOLECULAR CHARACTERIZATION OF DUARTE-1 AND DUARTE-2 VARIANTS OF GALACTOSE-1-PHOSPHATE URIDYLTRANSFERASE, Journal of inherited metabolic disease, 19(5), 1996, pp. 638-644
The N314D polymorphism was found in two different alleles of the galac
tose-1-phosphate uridyltransferase (GALT) gene, Duarte-1 (D1) and Duar
te-2 (D2). Although bath variants have identical electrophoretic mobil
ity and isoelectrofocusing points, the galactose-1-phosphate uridyltra
nsferase (GALT) activity varies: D1 aIleles showed 110-130% of the nor
mal RBC activity, but D2 alleles only 40-50%. We found that D1 alleles
also carried a silent mutation in exon 7 (L218L) in addition to N314D
. In contrast, besides N314D, D2 alleles carried two regulatory mutati
ons, G1105C and G1391A, in introns D and E, respectively. In normal an
d Q188R alleles none of the above four mutations coexisted, However, s
ome galactosaemia alleles with mutations other than Q 188R, such as W3
16X and E340X of exon 10, also carried the N314D mutation. The W316X
aIleles existed in cis with the intron mutations (G1105C and G1391A),
whereas those with E340X are in cis with L218L. In all cases examined,
the intron mutations were not found in D1 alleles and no D2 alleles h
ad the silent mutation of L218L. These results suggest that the decrea
se in the GALT activity in D2 may be due to regulation of the GALT gen
e expression. The G1105C site may be critical to the function of eryth
roid transcription factor NF-E1, since it flanks the core consensus se
quence for one of its binding sites. The G1391A mutation may affect an
other cia-acting regulatory sequence. Alternatively, both mutations ma
y be involved in an aberrant splice processing, which possibly results
in a low level of correctly spliced mRNA.